The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-modal and longitudinal characterization of the tumor and immune microenvironment from primary to in-transit and distant metastasis in acral melanoma.
 
Giuseppe Tarantino
No Relationships to Disclose
 
Anne Zaremba
No Relationships to Disclose
 
Tuulia Vallius
No Relationships to Disclose
 
Florian Rambow
No Relationships to Disclose
 
Roxanne Pelletier
No Relationships to Disclose
 
Samira Makhzami
No Relationships to Disclose
 
Lisa Zimmer
Stock and Other Ownership Interests - Bayer
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi; Sun Pharma
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi; Sun Pharma
 
Antje Sucker
No Relationships to Disclose
 
Elisabeth Livingstone
Honoraria - Bristol-Myers Squibb; Novartis; Pierre Fabre; Recordati; Sanofi; Sun Pharma; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Pierre Fabre; Sun Pharma
 
Eva Hadaschik
No Relationships to Disclose
 
Christine Lian
No Relationships to Disclose
 
George Murphy
No Relationships to Disclose
 
Peter Sorger
Leadership - Applied BioMath; Flagship Pioneering; Flagship Pioneering; Glencoe Software; NanoString Technologies; RareCyte
Stock and Other Ownership Interests - Applied BioMath; Glencoe Software; RareCyte
Honoraria - Novartis
Consulting or Advisory Role - Merck
Research Funding - Merck (Inst)
 
David Liu
No Relationships to Disclose
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Japan; Erasca, Inc; immatics; Immunocore; InflarxGmbH; LabCorp; Merck Serono; Merck Sharp & Dohme; NeraCare GmbH; Novartis; Novigenix; Pamgene; Pfizer; Philogen; Pierre Fabre; Regeneron; Replimune; Roche/Genentech; Sanofi/Regeneron; Seagen; Sun Pharma; Ultimovacs
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Erasca, Inc; immatics; Immunocore; Merck Sharp & Dohme; NeraCare GmbH; Novartis; Pierre Fabre; Replimune; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi/Regeneron
Research Funding - Amgen (Inst); Array BioPharma/Pfizer (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron